REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Wuhan Yzy Biopharma Co. Ltd. (China)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Wuhan Yzy Biopharma Co. Ltd. Profile Updated: March 16, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Chinese Download a sample report

Wuhan YZY Biopharma Co Ltd is engaged in the research, development, production and sales of pharmaceuticals. The Company is mainly engaged in the research, development and industrialization of bispecific antibody drugs. The Company's main products include anti-PD1&anti-CD3, anti-CD19&anti-CD3, and anti-CDX&CD3. The company was established in 2010 and is headquartered in WuhanCity, Hubei Province.

Headquarters
No. 666 Gaoxin Road, East Lake High Tech, Development Zone, Wuhan, Hubei Province
Wuhan; Hubei;

Contact Details: Purchase the Wuhan Yzy Biopharma Co. Ltd. report to view the information.

Basic Information
Total Employees:
Purchase the Wuhan Yzy Biopharma Co. Ltd. report to view the information.
Outstanding Shares:
Purchase the Wuhan Yzy Biopharma Co. Ltd. report to view the information.
Financial Auditors:
Purchase the Wuhan Yzy Biopharma Co. Ltd. report to view the information.
Incorporation Date:
July 08, 2010
Key Executives
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Director/Member of the Board
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Subsidiaries
Nanjing Youbodi (Hong Kong SAR, China)
100%
Shijiazhuang Shiyou (Hong Kong SAR, China)
100%
Wuhan Youwei (Hong Kong SAR, China)
100%
Company Performance
Financial values in the chart are available after Wuhan Yzy Biopharma Co. Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CNY. Absolute financial data is included in the purchased report.
Total operating revenue
473.49%▲
Operating profit (EBIT)
-1.54%▼
EBITDA
-1.41%▼
Net Profit (Loss) for the Period
-0.93%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo